Mg. Macey et al., Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry, CYTOMETRY, 38(4), 1999, pp. 153-160
The flow cytometric analysis of leucocytes in whole blood is usually perfor
med on samples in which the erythrocytes have been lysed and the leucocytes
fixed. Because lysis and fixation reagents have the potential to introduce
artefacts, several commercially available reagents were used to prepare no
rmal and leukaemic lymphocytes for immunophenotypic analysis by flow cytome
try, and the results were compared with those obtained from live whole bloo
d. The reagents tested were the ImmunoPrep system and Optilyse C (Coulter),
LF-1000-Lyse and Flow (Harlan), Uti-Lyse (Dako) and FAGS Lysing Solution (
Becton Dickinson). The effect of each reagent on the apparent expression of
CD3, CD5, GD11b, CD45, FMC7, kappa and lambda antigens was determined on l
ymphocytes from six normal controls and from six patients with chronic lymp
hocytic leukaemia (CLL). The following observations were made: (i) the time
in minutes for each procedure varied markedly and was 1.5, 15, 20, 30 and
30 for the ImmunoPrep system, Optilyse C, Uti-Lyse, FAGS Lysing Solution, a
nd LF-1000, respectively, but only 0.5 min for live whole blood. (ii) The f
orward and side scatter characteristics were affected by all of the lysis a
nd fixation procedures, and this was most marked for LF-1000-Lyse and Flow.
(iii) OptiLyse G gave preparations with poor forward and side scatter reso
lution due to the presence of residual red cell fragments. (iv) Lysis and f
ixation procedures did not affect the apparent expression of the GD3, CD45,
or FMG7 antigens on normal or CLL samples, but gave highly variable result
s for the expression of the CD5, CD11b, kappa, and lambda antigens on the C
LL samples. We conclude that lysis and fixation procedures can introduce di
fferent artefacts in the analysis of normal and leukaemic samples that are
best avoided by analysing live whole blood. (C) 1999 Wiley-Liss, Inc.